{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T01:34:53Z","timestamp":1792892093593,"version":"4.5.0"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The incidence and mortality of kala-azar (KA, visceral leishmaniasis) in India have fallen drastically in the past few years, and in 2023 the reported KA incidence reached the threshold for elimination as a public health problem (&amp;lt;1 case\/10 000 of population at subdistrict level). One of the strategies adopted by India's kala-azar elimination program (KAEP) was the regular independent assessment of the program implementation by teams of experts. We present the findings of assessments undertaken in 2019, 2021 and 2023, when the KAEP was in the last mile of elimination. Factors that contributed to its success were political commitment, intensified implementation, a strong network of KA partners and committed donors. Bottlenecks were observed in disease surveillance, data utilization, vector-control operations and program management at implementation. To sustain the gains and achieve validation of elimination, the KAEP should continue the following minimal essential services: optimized active and passive case detection and management of KA, post-KA dermal leishmaniasis, KA-HIV coinfection and relapse supported by vector-control interventions. Long-term measures that will sustain elimination are overall socioeconomic development, including improved living conditions, parallel with efficient surveillance and operational research that is aligned with the changing epidemiology of the disease.<\/jats:p>","DOI":"10.1093\/inthealth\/ihaf013","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T23:33:43Z","timestamp":1741131223000},"page":"416-422","source":"Crossref","is-referenced-by-count":16,"title":["Kala-azar elimination in India: reflections on success and sustainability"],"prefix":"10.1093","volume":"17","author":[{"given":"Dhruv K","family":"Pandey","sequence":"first","affiliation":[{"name":"World Heal , Pretoria 0002 ,","place":["South Africa"]},{"name":"th Organization, Country Office , Pretoria 0002 ,","place":["South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Alvar","sequence":"additional","affiliation":[{"name":"Royal Academy of Medicine , Madrid 28103 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1598-2206","authenticated-orcid":false,"given":"Margriet","family":"den Boer","sequence":"additional","affiliation":[{"name":"M\u00e9decins Sans Fronti\u00e8res , Amsterdam 1018DD ,","place":["Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Jain","sequence":"additional","affiliation":[{"name":"World Health Organization Department of Control of Neglected Tropical Diseases, , Geneva 1211 ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naresh","family":"Gill","sequence":"additional","affiliation":[{"name":"Directorate of National Centre for Disease Control , New Delhi 110054 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Argaw","sequence":"additional","affiliation":[{"name":"World Health Organization Department of Control of Neglected Tropical Diseases, , Geneva 1211 ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhash","family":"Salunke","sequence":"additional","affiliation":[{"name":"Public Health Foundation of India , New Delhi 110017 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mobassir","family":"Hussain","sequence":"additional","affiliation":[{"name":"Directorate of National Centre for Disease Control , New Delhi 110054 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nupur","family":"Roy","sequence":"additional","affiliation":[{"name":"Directorate of National Centre for Disease Control , New Delhi 110054 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,3,3]]},"reference":[{"issue":"99","key":"2025070112465187300_bib1","first-page":"653","article-title":"Global leishmaniasis surveillance updates 2023: 3 years of the NTD Road map","volume":"45","year":"2024","journal-title":"WER"},{"issue":"6","key":"2025070112465187300_bib2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S2214-109X(13)70078-0","article-title":"The drug and vaccine landscape for neglected diseases (2000-11): A systematic assessment","volume":"1","author":"Pedrique","year":"2013","journal-title":"Lancet Glob Health"},{"key":"2025070112465187300_bib3"},{"key":"2025070112465187300_bib4"},{"issue":"4","key":"2025070112465187300_bib5","doi-asserted-by":"crossref","first-page":"802","DOI":"10.4269\/ajtmh.16-0279","article-title":"Elimination of Kala-Azar from the Southeast Asia Region","volume":"96","author":"Bhattacharya","year":"2017","journal-title":"Am J Trop Med Hyg"},{"key":"2025070112465187300_bib6","article-title":"NCVBDC Kala-Azar Situation in India"},{"key":"2025070112465187300_bib7"},{"key":"2025070112465187300_bib8","article-title":"Independent assessment of kala-azar elimination programme in India","author":"World Health Organization","year":"2020"},{"issue":"11","key":"2025070112465187300_bib9","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1080\/14787210.2022.2126352","article-title":"Visceral leishmaniasis elimination in India: Progress and the road ahead","volume":"20","author":"Singh","year":"2022","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2025070112465187300_bib10","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1469-0691.2011.03635.x","article-title":"Leishmaniasis impact and treatment access","volume":"17","author":"Den Boer","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"2025070112465187300_bib11"},{"key":"2025070112465187300_bib12","doi-asserted-by":"crossref","first-page":"604117","DOI":"10.3389\/fcimb.2021.604117","article-title":"Visceral Leishmaniasis-HIV coinfection as a predictor of increased Leishmania transmission at the village level in Bihar","volume":"11","author":"Cloots","year":"2021","journal-title":"India Front Cell Infect Microbiol"},{"key":"2025070112465187300_bib13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4269\/ajtmh.1999.60.51","article-title":"Infection of sand flies by humans coinfected with Leishmania infantum and human immunodeficiency virus","volume":"60","author":"Molina","year":"1999","journal-title":"Am J Trop Med Hyg"},{"key":"2025070112465187300_bib14","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/cid\/ciu333","article-title":"HIV and visceral leishmaniasis coinfection in Bihar, India: An underrecognized and underdiagnosed threat against elimination","volume":"59","author":"Burza","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2025070112465187300_bib15","volume-title":"WHO guidelines for the treatment of visceral leishmaniasis in HIV co-infected patients in East Africa and South-East Asia","year":"2022"},{"issue":"392","key":"2025070112465187300_bib16","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"15","author":"Burza","year":"2018","journal-title":"Lancet"},{"key":"2025070112465187300_bib17","first-page":"341","article-title":"Ten years of kala-azar in west Bengal, Part I. Did post-kala-azar dermal leishmaniasis initiate the outbreak in 24-Parganas?","volume":"70","author":"Addy","year":"1992","journal-title":"Bull World Health Organ"},{"key":"2025070112465187300_bib18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/cid\/ciy891","article-title":"Quantifying the infectiousness of post-Kala-azar dermal leishmaniasis toward sand flies","volume":"69","author":"Mondal","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2025070112465187300_bib19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13071-020-04011-7","article-title":"Report of the Fifth Post-Kala-Azar Dermal Leishmaniasis Consortium Meeting, Colombo, Sri Lanka, 14\u201316 May 2018","volume":"13","author":"Zijlstra","year":"2020","journal-title":"Parasit Vectors"},{"key":"2025070112465187300_bib20","doi-asserted-by":"crossref","first-page":"e0007249","DOI":"10.1371\/journal.pntd.0007249","article-title":"Active surveillance identified a neglected burden of macular cases of Post Kala-azar Dermal Leishmaniasis in West Bengal","volume":"13","author":"Sengupta","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"2025070112465187300_bib21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4103\/0972-9062.310875","article-title":"Changing clinico-epidemiology of post-kala-azar dermal leishmaniasis (PKDL) in India: Results of a survey in four endemic states","volume":"57","author":"Saurabh","year":"2020","journal-title":"J Vector Borne Dis"},{"key":"2025070112465187300_bib22","article-title":"Advisory Committee on Safety of Medicinal Products (ACSoMP): Measures to minimize the risk of ocular adverse events with miltefosine"},{"issue":"6","key":"2025070112465187300_bib23","doi-asserted-by":"crossref","first-page":"e001224","DOI":"10.1371\/journal.pntd.0012242","article-title":"A phase II, non-comparative randomised trial of two treatments involving liposomal amphotericin B and miltefosine for post-kala-azar dermal leishmaniasis in India and Bangladesh","volume":"18","author":"Sundar","year":"2024","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"2025070112465187300_bib24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1179\/136485911X12899838683124","article-title":"The Indian and Nepalese programmes of indoor residual spraying for the elimination of visceral leishmaniasis: Performance and effectiveness","volume":"105","author":"Chowdhury","year":"2011","journal-title":"Ann Trop Med Parasitol"},{"key":"2025070112465187300_bib25","doi-asserted-by":"crossref","first-page":"e0006846","DOI":"10.1371\/journal.pntd.0006846","article-title":"Indoor residual spraying for kala-azar vector control in Bangladesh: A continuing challenge","volume":"12","author":"Chowdhury","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"2025070112465187300_bib26","doi-asserted-by":"crossref","first-page":"e0006168","DOI":"10.1371\/journal.pntd.0006168","article-title":"Bionomics of Phlebotomus argentipes in villages in Bihar, India with insights into efficacy of IRS-based control measures","volume":"12","author":"Poch\u00e9","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"2025070112465187300_bib27","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13071-020-04551-y","article-title":"Visceral leishmaniasis outbreaks in Bihar: Community-level investigations in the context of elimination of kala-azar as a public health problem","volume":"14","author":"Priyamvada","year":"2021","journal-title":"Parasit Vectors"},{"issue":"5","key":"2025070112465187300_bib28","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"key":"2025070112465187300_bib29","volume-title":"Ending the neglect to attain the Sustainable Development Goals: a strategic framework for integrated control and management of skin-related neglected tropical diseases","year":"2022"},{"issue":"96","key":"2025070112465187300_bib30","first-page":"267","article-title":"Kala-azar in India\u2014progress and challenges towards its elimination as a public health problem","volume":"26","author":"Gill","year":"2021","journal-title":"WER"},{"key":"2025070112465187300_bib31","volume-title":"Independent assessment of Kala-azar Elimination Programme India","year":"2020"},{"key":"2025070112465187300_bib32","article-title":"Ending the neglect to attain the Sustainable Development Goals: A road map for neglected tropical diseases 2021\u20132030","year":"2021","journal-title":"WHO"},{"key":"2025070112465187300_bib33","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1365-3156.2012.02960.x","article-title":"Low castes have poor access to visceral leishmaniasis treatment in Bihar, India","volume":"17","author":"Pascual Mart\u00ednez","year":"2012","journal-title":"Trop Med Int Health"},{"key":"2025070112465187300_bib34"},{"key":"2025070112465187300_bib35"},{"key":"2025070112465187300_bib36","first-page":"1","article-title":"Insights from mathematical modelling and quantitative analysis on the proposed WHO 2030 targets for visceral leishmaniasis on the Indian subcontinent","volume":"3","author":"Adams","year":"2019","journal-title":"Gates Open Res"},{"issue":"2","key":"2025070112465187300_bib37","doi-asserted-by":"crossref","first-page":"e2053","DOI":"10.1371\/journal.pntd.0002053","article-title":"Latent infection with Leishmania donovani in highly endemic villages in Bihar, India","volume":"7","author":"Hasker","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"12","key":"2025070112465187300_bib38","doi-asserted-by":"crossref","first-page":"e1763","DOI":"10.1016\/S2214-109X(21)00392-2","article-title":"Towards the elimination of visceral leishmaniasis as a public health problem in east Africa: Reflections on an enhanced control strategy and a call for action","volume":"9","author":"Alvar","year":"2021","journal-title":"Lancet Glob Health"}],"container-title":["International Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/inthealth\/article-pdf\/17\/4\/416\/62226751\/ihaf013.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/inthealth\/article-pdf\/17\/4\/416\/62226751\/ihaf013.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T16:47:23Z","timestamp":1751388443000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/inthealth\/article\/17\/4\/416\/8050720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,3]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,3,3]]},"published-print":{"date-parts":[[2025,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/inthealth\/ihaf013","relation":{},"ISSN":["1876-3413","1876-3405"],"issn-type":[{"value":"1876-3413","type":"print"},{"value":"1876-3405","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7]]},"published":{"date-parts":[[2025,3,3]]}}}